The effect of chlorophenoxyisobutyrate on plasma composition of cholesteryl esters and on levels of neutral lipids
- 1 January 1968
- journal article
- research article
- Published by Elsevier in Journal of Atherosclerosis Research
- Vol. 8 (1) , 21-27
- https://doi.org/10.1016/s0368-1319(68)80075-4
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Clinical Trial with Ethyl-α-p-Chlorophenoxyisobutyrate (Atromid-S) with Special Reference to White Blood Cell CountsActa Medica Scandinavica, 2009
- Effect of CPIB ester on plasma free fatty acid levels in manMetabolism, 1966
- EFFECT OF ETHYLCHLORO-PHENOXYISOBUTYRATE ON WEIGHT, PLASMA VOLUME, TOTAL BODY-WATER, AND FREE FATTY ACIDSThe Lancet, 1965
- Cholesterol Ester MetabolismPhysiological Reviews, 1965
- The effects of ethyl chlorophenoxyisobutyrate on serum cholesteryl, triglyceride and phospholipid fatty acidsJournal of Atherosclerosis Research, 1963
- Further observations on the effects of atromid and of ethyl chlorophenoxyisobutyrate on serum lipid levelsJournal of Atherosclerosis Research, 1963
- The effects of atromid on the metabolism of adrenal steroids and on plasma lipid fractionsJournal of Atherosclerosis Research, 1963
- Changes in serum lipids with atromid and chlorophenoxyisobutyric esterJournal of Atherosclerosis Research, 1963
- Isolationof neutral lipids by column chromatographyJournal of Oil & Fat Industries, 1961
- Effects of Estrogen Therapy on Hormonal Functions and Serum Lipids in Men with Coronary AtherosclerosisCirculation, 1956